These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 20716954)
1. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma. Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma. Li JY; Han C; Zheng LL; Guo MZ Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318 [TBL] [Abstract][Full Text] [Related]
3. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122 [TBL] [Abstract][Full Text] [Related]
4. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells. Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502 [TBL] [Abstract][Full Text] [Related]
6. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer. Li L; Yang WT; Zheng PS; Liu XF Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906 [TBL] [Abstract][Full Text] [Related]
7. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer. Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431 [TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma. Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368 [TBL] [Abstract][Full Text] [Related]
10. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Yamashita T; Budhu A; Forgues M; Wang XW Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828 [TBL] [Abstract][Full Text] [Related]
11. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells. Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329 [TBL] [Abstract][Full Text] [Related]
12. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells. Ma L; Wang X; Jia T; Wei W; Chua MS; So S Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473 [TBL] [Abstract][Full Text] [Related]
13. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway. Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492 [TBL] [Abstract][Full Text] [Related]
14. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists. Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888 [TBL] [Abstract][Full Text] [Related]